Ken Griffin’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-168,272
| Closed | -$65K | – | 10904 |
|
|
2020
Q1 | $65K | Buy |
168,272
+66,143
| +65% | +$23.9K | ﹤0.01% | 8903 |
|
|
2019
Q4 | $42K | Buy |
+102,129
| New | +$170K | ﹤0.01% | 8802 |
|
|
2019
Q3 | – | Sell |
-25,391
| Closed | -$51.4K | – | 10071 |
|
|
2019
Q2 | $55K | Buy |
25,391
+8,177
| +48% | +$20.9K | ﹤0.01% | 8703 |
|
|
2019
Q1 | $54K | Buy |
17,214
+2,015
| +13% | +$6.52K | ﹤0.01% | 8795 |
|
|
2018
Q4 | $38K | Buy |
15,199
+2,194
| +17% | +$7.3K | ﹤0.01% | 8557 |
|
|
2018
Q3 | $52K | Buy |
+13,005
| New | +$57.3K | ﹤0.01% | 8801 |
|
|
2017
Q4 | – | Sell |
-16,339
| Closed | -$35K | – | 8670 |
|
|
2017
Q3 | $35K | Sell |
16,339
-2,768
| -14% | -$9.42K | ﹤0.01% | 7261 |
|
|
2017
Q2 | $86K | Buy |
19,107
+4,971
| +35% | +$18K | ﹤0.01% | 6958 |
|
|
2017
Q1 | $42K | Sell |
14,136
-14,172
| -50% | -$41.8K | ﹤0.01% | 7091 |
|
|
2016
Q4 | $78K | Buy |
28,308
+3,969
| +16% | +$11.3K | ﹤0.01% | 6761 |
|
|
2016
Q3 | $76K | Buy |
24,339
+8,262
| +51% | +$30.1K | ﹤0.01% | 6743 |
|
|
2016
Q2 | $82K | Buy |
+16,077
| New | +$77.3K | ﹤0.01% | 6275 |
|
|
2016
Q1 | – | Sell |
-11,598
| Closed | -$94K | – | 8524 |
|
|
2015
Q4 | $94K | Buy |
11,598
+3,956
| +52% | +$33K | ﹤0.01% | 6766 |
|
|
2015
Q3 | $64K | Sell |
7,642
-10,390
| -58% | -$95.7K | ﹤0.01% | 7401 |
|
|
2015
Q2 | $170K | Buy |
18,032
+12,896
| +251% | +$120K | ﹤0.01% | 6516 |
|
|
2015
Q1 | $48K | Buy |
5,136
+1,095
| +27% | +$10.5K | ﹤0.01% | 7413 |
|
|
2014
Q4 | $37K | Buy |
+4,041
| New | +$34K | ﹤0.01% | 7417 |
|
|
2014
Q3 | – | Sell |
-11,086
| Closed | -$80.7K | – | 8558 |
|
|
2014
Q2 | $87K | Sell |
11,086
-11,443
| -51% | -$86.4K | ﹤0.01% | 6341 |
|
|
2014
Q1 | $178K | Buy |
22,529
+8,088
| +56% | +$65.1K | ﹤0.01% | 5632 |
|
|
2013
Q4 | $90K | Buy |
14,441
+3,659
| +34% | +$19.2K | ﹤0.01% | 5694 |
|
|
2013
Q3 | $38K | Buy |
10,782
+4,918
| +84% | +$11.2K | ﹤0.01% | 5935 |
|
|
2013
Q2 | $11K | Buy |
+5,864
| New | +$11.8K | ﹤0.01% | 6222 |
|
Ken Griffin's CORV Position: Q2 2020 in Review
Ken Griffin sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 168,272 shares — an estimated $65K sold.
Ken Griffin first reported a position in CORV in Q2 2013 and held it in 22 quarters. The position peaked at $178K in Q1 2014. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.
- Ken Griffin reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
- Ken Griffin sold 168,272 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $65K.
- Ken Griffin first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 22 quarters.
- Ken Griffin's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $178K in Q1 2014.
- 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.